Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of the Photobiomodulation Device ELIXIR in Postoperative Plastic Surgery: A Randomized Clinical Trial

NCT07676643 is registered in ClinicalTrials.gov with Elixir MD Inc as lead sponsor.

NCT NCT07676643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07676643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of the Photobiomodulation Device ELIXIR in Postoperative Plastic Surgery: A Randomized Clinical Trial
Lead sponsor
Elixir MD Inc
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 9, 2025
Completion date
October 31, 2026
Enrollment
148 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plastic surgery, postoperative complications